18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation

Citer cette référence
IMPERIALE, A., RUST, E., GABRIEL, S., DETOUR, J., GOICHOT, Bernard, DUCLOS, B., KURTZ, J. E., BACHELLIER, P., NAMER, I. J. et TAIEB, D., 2014. 18F-fluorodihydroxyphenylalanine PET/CT in patients with neuroendocrine tumors of unknown origin: relation to tumor origin and differentiation. The Journal of Nuclear Medicine [en ligne]. 2014. Vol. 55, n° 3pp. 367-372. [Consultésans date]. DOI 10.2967/jnumed.113.126896. Consulté de : http://www.ncbi.nlm.nih.gov/pubmed/24343986